Growth and Overall Health of Patients with <i>SLC13A5</i> Citrate Transporter Disorder
We were interested in elucidating the non-neurologic health of patients with autosomal recessive <i>SLC13A5</i> Citrate Transporter (NaCT) Disorder. Multiple variants have been reported that cause a loss of transporter activity, resulting in significant neurologic impairment, including s...
Guardado en:
Autores principales: | Tanya L. Brown, Kimberly L. Nye, Brenda E. Porter |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/295c0f16012f45c28b1cd63939c1d7cc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Evidence for a Genotype–Phenotype Correlation in Patients with Pathogenic <i>GLUT2</i> (<i>SLC2A2</i>) Variants
por: Sarah C. Grünert, et al.
Publicado: (2021) -
Diethyl citrate and sodium citrate reduce the cytotoxic effects of nanosized hydroxyapatite crystals on mouse vascular smooth muscle cells
por: Zhang CY, et al.
Publicado: (2017) -
A Study on Clinical and Pathological Responses to Neoadjuvant Chemotherapy in Breast Carcinoma
por: Kunnuru SKR, et al.
Publicado: (2020) -
Renal Hypouricemia 1: Rare Disorder as Common Disease in Eastern Slovakia Roma Population
por: Blanka Stiburkova, et al.
Publicado: (2021) -
The Relationship of <i>ABCB1/MDR1</i> and <i>CYP1A1</i> Variants with the Risk of Disease Development and Shortening of Overall Survival in Patients with Multiple Myeloma
por: Szymon Zmorzynski, et al.
Publicado: (2021)